ROBERTS BRANDI (Chief Financial Officer) received a stock award from DEFINIUM THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/14/2026ACC: 0001193125-26-389888
Officer· Chief Financial Officer
Since Feb 2026
+125K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
125K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+125K
Price / share
—
Trade value
—
% of position
45.8%
9/14/2026
272.90K→397.90K
Total
Net shares
+125K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 9/14/2026 | A · Award | +125K | — | — | 45.8% | 272.90K | 397.90K |
| Total | +125K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported